Severe aortic stenosis patient risk during the COVID-19 pandemic

Open Heart. 2020 Sep;7(2):e001355. doi: 10.1136/openhrt-2020-001355.
No abstract available

Keywords: aortic valve disease; coagulation factors; haematology; public health; valvular disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aortic Valve Stenosis / diagnostic imaging
  • Aortic Valve Stenosis / mortality
  • Aortic Valve Stenosis / surgery*
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Clinical Decision-Making
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / mortality
  • Coronavirus Infections* / transmission
  • Coronavirus Infections* / virology
  • Health Status
  • Heart Valve Prosthesis Implantation* / adverse effects
  • Heart Valve Prosthesis Implantation* / mortality
  • Host-Pathogen Interactions
  • Humans
  • Pandemics*
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / mortality
  • Pneumonia, Viral* / transmission
  • Pneumonia, Viral* / virology
  • Risk Assessment
  • Risk Factors
  • SARS-CoV-2
  • Severity of Illness Index
  • Time Factors
  • Time-to-Treatment
  • Transcatheter Aortic Valve Replacement